Center for the Evaluation of Value and Risk in Health (CEVR)

What does the future hold for CEA? Hear from experts Davene R. Wright, PhD, Fernando Alarid-Escudero, Norah L Crossnohere, and David D. Kim during Panel 5 at the 10/26 Tufts-CEVR / Duke Margolis symposium. Register now: In-person: https://lnkd.in/euMDsjC4 Webinar: https://lnkd.in/eApJzSwS

We are pleased to announce that Brian Reid, a nationally-recognized expert in prescription drug policy and communications, has joined CEVR as a Senior Fellow. As readers of his incisive Cost Curve newsletter know, Brian brings extensive expertise in key areas of drug policy, including drug value assessment, prescription drug pricing, and access.?While at CEVR, he will focus on these topics, as well as the implications of the Inflation Reduction Act (#IRA) on the pharmaceutical industry and the impact of pharmacy benefit managers (#PBMs) on costs and access. ? We look forward to working with Brian on our research agenda and helping to communicate our work to policymakers, journalists, and the public Read more at: https://lnkd.in/eXRJyp7k

Join CEVR in Las Vegas for #AMCPNexus 2024. Highlights include two educational sessions by James Chambers and Molly Beinfeld's presentation of Fariel LaMountain's Platinum Ribbon-winning research on adalimumab product coverage. CEVR's Daniel Enright will present a poster on commercial coverage of semaglutide/tirzepatide for obesity management. Julia Rucker, MSW/MPH will present a poster on alignment of commercial health plan utilization management criteria with clinical treatment guidelines. Zach Rivers, PharmD, PhD will present a poster on his research that used the SPEC database to to examine the complexity and restrictiveness of supportive care coverage in a real-world cohort of patients with cancer A full list of CEVR participation can be found here: https://lnkd.in/djYMCGqv

What is the role of #CEA in public policy, and what should it be going forward? Hear from Sarah Emond, Rena Conti, Lou Garrison, Steve Kymes, and Lisa Prosser during Panel 4 at the 10/26 Tufts-CEVR / Duke Margolis symposium to celebrate CEA. ? Register now: ? In-Person: https://lnkd.in/euMDsjC4 ? Webinar: https://lnkd.in/eApJzSwS

What does the future hold for the QALY - replacement or revision? Join CEVR for an online health policy seminar led by Chris Sampson, Senior Principal Economist at Office of Health Economics, to find out. Webinar will be held on October 3 from 2-3 pm ET. Details and join link here: https://lnkd.in/eh6aYacY

Eager to learn about new #CEA methods from leading scientists at the forefront of value assessment? Join Anirban Basu, Darius Lakdawalla, Melanie Whittington, and Beth Woods during the 3rd Panel at the October 26 symposium hosted by the Center for the Evaluation of Value and Risk in Health (CEVR) and Duke-Margolis Institute for Health Policy. Register now: In Person: https://lnkd.in/euMDsjC4 Webinar: https://lnkd.in/eApJzSwS

The second panel at October 26 Center for the Evaluation of Value and Risk in Health (CEVR) / Duke-Margolis Institute for Health Policy symposium will feature reflections on CEA from three luminaries: Ankur Pandya, Marthe Gold, and Charles Phelps. Register now: In Person (Boston): https://lnkd.in/eCvPbxjb Webinar: https://lnkd.in/eApJzSwS

We are excited to announce the speakers for the first of five panels at the October 26 Center for the Evaluation of Value and Risk in Health (CEVR) and Duke-Margolis Institute for Health Policy Special Symposium to Celebrate Cost-Effectiveness Analysis: Scott Cantor, Patricia Synnott, and Meng Li. We will announce speakers for the remaining four panels over the next few weeks. Register now! In-person (Boston): https://lnkd.in/eCvPbxjb Webinar: https://lnkd.in/eApJzSwS

We examined community members' preferences for nine common health gain measures. Despite controversy, they ranked the QALY highest, followed by clinical benefit rating and multi-criteria decision analysis (MCDA). Key recommendations: use patient values, combine complementary measures, and prioritize simple tools. #QALY #HTA Authors are Ching-Hsuan(Ching) Lin, Tara Lavelle, Marie Phillips, Abigail Riley, and Dan Ollendorf. Thanks to the The Commonwealth Fund for sponsoring this research https://lnkd.in/eQfWFJAW

What does the future hold for Medicare's #CED program? On 9/25, CEVR's Peter Neumann will share his perspective on reform at an event hosted in partnership with the USC Schaeffer Center for Health Policy & Economics and the Stanford Mussallem Center for Biodesign in DC. Register here: https://lnkd.in/gA855H8g